A novel device for conservation of supplemental oxygen: A randomized, crossover study of the efficiency and non-inferiority of the OXFO System

Kelly M Wawrzyniak, Giles Hooker, Susana Cristina Osorno Upegui, Rommer Alex Ortega Martínez, Adriana Bazoberry, David DiBenedetto, Bridget Young, Carlos F BazoberryJournal of Global Health Reports 2024 · DOI

Abstract

Oxygen is critical to the prevention of hypoxemia-induced morbidity and mortality; yet, access remains inadequate in most low- and middle-income countries (LMICs) despite billions of dollars spent over decades to increase supply. We present a new method for supplemental oxygen delivery whereby the OXFO System (OXFO Corporation, Boston, MA, USA) converts pressurized oxygen to ambient pressure for patient inhalation on demand at a fixed concentration across fluctuations in respiratory rate or tidal volume. This study’s primary aims were to examine the oxygen volume savings and test the non-inferiority of mean peripheral oxygen saturation ($SpO_2$) with the OXFO System (OXFO Condition) compared to conventional continuous flow (Standard Condition) in a clinical population of oxygen-dependent hospitalized adults.

Introduction

Supplemental oxygen is a fundamental medicine, yet the COVID-19 pandemic underscored a persistent global health crisis: the lack of reliable oxygen access in low- and middle-income countries (LMICs). A primary driver of this scarcity is the inherent wastefulness of standard delivery methods. Continuous flow systems dispense oxygen throughout the entire respiratory cycle, meaning a significant portion of the gas is lost to the environment during exhalation.

While various oxygen-conserving devices (OCDs) like reservoir cannulas or pulse-demand systems exist, they often suffer from an "efficiency-effectiveness" trade-off. These devices frequently lose performance at higher flow rates or cause patient discomfort due to the pressurized nature of the delivery. The OXFO System was developed to provide high-efficiency conservation without sacrificing patient oxygenation, even at higher clinical doses.

The OXFO System Mechanism

The OXFO System represents a novel approach to oxygen conservation by decoupling delivery pressure from inhalation. Unlike traditional systems that deliver pressurized gas, the OXFO device converts pressurized oxygen into an internal ambient-pressure reservoir bag.

Internal components of the OXFO device, highlighting the ambient-pressure reservoir bag (5) and control electronics.

As shown in the internal schematic, infrared sensors monitor the volume of this reservoir bag. When a patient inhales and the bag collapses, a solenoid valve opens to refill it. This "on-demand" delivery at ambient pressure allows patients to draw exactly the volume they need with each breath, a process the authors compare to drinking from a glass with a straw rather than a pressurized hose.

Methods

To validate this technology, researchers conducted a single-visit, randomized, crossover, non-inferiority study at a hospital in Medellín, Colombia. The study included 19 oxygen-dependent hospitalized adults (ages 43–70) with primary diagnoses including COPD, Congestive Heart Failure (CHF), and pneumonia. All patients were already prescribed supplemental oxygen at doses of at least 2 L/min.

Schematic of the OXFO System setup, including the oxygen source (1), regulator (2), and delivery device (4).

Subjects were randomized to receive either the OXFO Condition or the Standard Condition (continuous flow) first. For each condition, oxygen was titrated to reach a target therapeutic $SpO_2$ (e.g., 94% for non-hypercapnic patients). Following titration, physiological data and oxygen consumption were recorded for 20 minutes. The primary endpoints were the ratio of oxygen volume dispensed and the mean $SpO_2$ levels.

Results

The clinical trial revealed massive efficiency gains. The OXFO System used a mean of only 7.7% (SD=5.4%) of the oxygen required by the Standard Condition ($P < 0.001$). This represents a nearly 13-fold reduction in oxygen consumption. Notably, this efficiency remained robust across the entire tested range (up to 6 L/min), maintaining a ~92% savings ratio regardless of the dose.

Regarding clinical efficacy, the OXFO System demonstrated clear non-inferiority. The mean $SpO_2$ for the OXFO Condition was 91.07% (SD=2.20%) compared to 91.35% (SD=1.62%) for the Standard Condition. The difference was well within the pre-defined non-inferiority margin of -2.8% ($P < 0.001$). Furthermore, there were no significant differences in patient-reported dyspnea (shortness of breath) or discomfort, suggesting the system is well-tolerated.

Discussion and Conclusion

The OXFO System successfully maintains clinical oxygenation while drastically reducing the volume of gas required. The observed 13x savings exceeded initial bench-test predictions of 5x, likely because the device allows for more precise titration to a patient's actual physiological needs in a clinical setting compared to the "blunt instrument" of continuous flow.

While the study was limited by its short duration (20 minutes) and single-center design, the results are promising for oxygen-scarce environments. By extending the life of oxygen cylinders by an order of magnitude, such technology could significantly reduce the logistical burden and costs of oxygen delivery in LMICs. Future research should focus on long-term use, including sleep and physical activity, to confirm the system's utility in broader clinical and home-care contexts.

Summary updated

Abstract

Background Oxygen is critical to the prevention of hypoxemia-induced morbidity and mortality; yet, access remains inadequate in most low- and middle-income countries despite billions of dollars spent over decades to increase supply. We present a new method for supplemental oxygen delivery whereby the OXFO System (OXFO Corporation, Boston, MA, USA) converts pressurized oxygen to ambient pressure for patient inhalation on demand at a fixed concentration across fluctuations in respiratory rate or tidal volume. This study’s primary aims were to examine the oxygen volume savings and test the non-inferiority of mean peripheral oxygen saturation (S pO2 ) with the OXFO System (OXFO Condition) compared to conventional continuous flow (Standard Condition) in a clinical population of oxygen-dependent hospitalized adults. Methods We conducted a non-inferiority, single-visit, randomized, crossover design. A total of 20 subjects were randomized to receive either OXFO Condition or Standard Condition first. Subjects were administered oxygen for 20 minutes during each condition after oxygen was titrated to target therapeutic S pO2 . A one-sample t-test was performed to compare the mean ratio of oxygen volume dispensed (OXFO Condition/Standard Condition) with 100%. A paired t-test for non-inferiority was used to test the hypothesis that the mean S pO2 for OXFO Condition is no worse than 2.8% lower (absolute difference) than the mean S pO2 for Standard Condition. Results Nineteen subjects were included in the analyses. When considering the dispensing of oxygen as a ratio (OXFO Condition / Standard Condition) for each subject, the mean was 7.7% (standard deviation(SD)=5.4%; range=0-20%) and this was significantly different from 100% ( P &lt;0.001). The savings ratio was not significantly correlated with Standard Condition rate of flow ( P =0.23). Mean S pO2 for OXFO Condition was 91.07% (SD=2.20%) and 91.35% (SD=1.62%) for Standard Condition and the difference was significantly above the non-inferiority margin of -2.80% ( P &lt;0.001). Conclusions The OXFO System saves a significant volume of oxygen while achieving non-inferior mean saturation for hospitalized oxygen-dependent patients. The OXFO System appears to maintain robust volume savings of nearly 13x across doses up to 6 liters per minute (L/min). This has significant implications for advancing equitable access to oxygen.
BibTeX
@article{wawrzyniak2024novel,
  author = {Kelly M Wawrzyniak and Giles Hooker and Susana Cristina Osorno Upegui and Rommer Alex Ortega Martínez and Adriana Bazoberry and David DiBenedetto and Bridget Young and Carlos F Bazoberry},
  title = {{A novel device for conservation of supplemental oxygen: A randomized, crossover study of the efficiency and non-inferiority of the OXFO System}},
  journal = {Journal of Global Health Reports},
  year = {2024},
  doi = {10.29392/001c.124467},
}

Loading related content...

Figure